In the absence of intestinally derived FGF15, VSG leads to an even greater increase in hydrophobic bile acids which we speculate leads to anemia of chronic disease and increased EPO and FGF23 levels that likely contribute to great loss of bone mass, BMAT, muscle mass, and cardiac hypertrophy. This evidence concerns the gene EPO and cardiac hypertrophy.